In vitro fertilization (IVF) has helped many couples overcome fertility challenges, but treatment outcomes can vary significantly from person to person. For patients who respond poorly to ovarian stimulation or experience repeated unsuccessful IVF cycles, doctors sometimes explore additional therapies that may improve results. One of the approaches that has gained attention in recent years is the use of human growth hormone (HGH) during IVF treatment.

Although HGH is primarily known for its role in growth and metabolism, researchers have investigated whether it may also support ovarian function, egg quality, and embryo development in certain fertility patients.

What Is Human Growth Hormone?

Human growth hormone is naturally produced by the pituitary gland and plays an important role in cell growth, tissue repair, metabolism, and regeneration. In reproductive medicine, HGH is sometimes used as an additional treatment alongside standard IVF protocols.

The idea behind this approach is that HGH may influence the ovarian environment and improve how follicles respond to stimulation medications during the IVF process.

Why HGH Is Used During IVF

During IVF treatment, patients receive hormonal medications designed to stimulate the ovaries and encourage the development of multiple eggs. Some women, particularly those classified as “poor responders,” may produce fewer eggs despite aggressive stimulation protocols.

Researchers believe HGH may help improve ovarian responsiveness in these situations. Some studies suggest that growth hormone may support granulosa cell activity and insulin-like growth factor-1 (IGF-1) pathways, which are involved in follicle and oocyte development.

Because of this potential effect, HGH is sometimes added to IVF treatment plans for patients with diminished ovarian reserve, advanced maternal age, or previous unsuccessful cycles.

Potential Benefits of HGH in Fertility Treatment

Several studies have explored whether HGH supplementation can improve IVF outcomes. Some reported possible benefits such as:

• Increased number of retrieved eggs
• Improved embryo quality
• Better ovarian response to stimulation
• Higher clinical pregnancy rates in some patients

Meta-analyses examining poor ovarian responders have suggested that HGH may improve certain intermediate IVF outcomes, although the quality of evidence remains limited.

Some fertility specialists also believe HGH may help support egg quality in older patients, though results are not consistent across all studies.

The Limits of Current Research

Despite growing interest in HGH therapy for IVF, researchers continue to debate its effectiveness. Large clinical reviews note that evidence remains mixed, and many studies involve relatively small patient groups or differing treatment protocols.

A randomized placebo-controlled trial found no significant improvement in live birth rates when HGH was added to IVF cycles for poor responders.

Because of these conflicting findings, HGH is not considered a universal solution for infertility or IVF failure. Instead, it is usually viewed as a possible adjunct therapy for selected patients under medical supervision.

Who May Be Considered for HGH Therapy?

Fertility clinics may consider HGH supplementation in cases involving:

• Poor ovarian response
• Low egg yield in previous IVF cycles
• Advanced reproductive age
• Reduced ovarian reserve
• Repeated implantation failure

However, treatment decisions depend on many factors, including hormone levels, medical history, ovarian reserve testing, and previous IVF outcomes.

Doctors typically individualize IVF protocols rather than applying the same HGH approach to every patient.

Patient Experiences and Online Discussions

Online fertility communities often contain mixed experiences regarding HGH during IVF. Some patients report improved embryo quality or higher egg numbers after adding HGH to their protocols, while others notice little difference.

These discussions reflect the uncertainty that still surrounds HGH treatment in reproductive medicine. Individual responses can vary considerably depending on age, diagnosis, egg quality, and overall fertility health.

Possible Risks and Considerations

Like many hormonal therapies, HGH treatment may involve side effects or additional costs. Reported side effects can include:

• Fluid retention
• Joint discomfort
• Headaches
• Injection site reactions

Because HGH protocols vary widely between clinics, patients are usually advised to discuss both benefits and risks carefully with fertility specialists before beginning treatment.

The Future of HGH in IVF

Researchers continue studying how growth hormone may influence ovarian function and embryo development. Future clinical trials may help determine which patient groups are most likely to benefit and what dosing strategies are most effective.

At present, Human Growth Hormone for IVF remains an optional adjunct treatment rather than a standard component of every IVF cycle. While some evidence suggests potential advantages for poor responders, experts generally agree that more high-quality research is still needed to confirm long-term effectiveness and live birth outcomes.